Dr. Axel Müller, born in 1957, has been a member of the Supervisory Board since 2018. As of 8th, April 2019 he is deputy chairman of the Supervisory Board of Mutares SE & Co. KGaA
From 1985 to 2010, Dr. Axel Müller held numerous management positions at STADA Arzneimittel AG in the areas of Marketing and Communication, Strategy and M&A as well as Operations; most recently as a member of the Executive Board since 2010, he was responsible for Production and Development. Dr. Axel Müller has been an independent management consultant since 2014. After several years as Senior Advisor at Arthur D. Little, he became Associate Partner at Fidelio Healthcare Partners in 2018.
Dr. Axel Müller is a licensed pharmacist; after completing his pharmaceutical studies at the Johannes-Gutenberg University in Mainz in 1980, he worked there for several years as a research assistant and received his doctorate in pharmaceutical technology.
|2014 – today||Independent Management Consultant|
|2010 – 2013||Chief Production and Development Officer of STADA Arzneimittel AG|
|1993 – 2010||Advice to the Executive Board of STADA Arzneimittel AG|
|1985 – 1993||Various management positions at STADA Arzneimittel AG|
|1980 – 1985||Research assistant at the Chair of Pharmaceutical Technology at the Johannes-Gutenberg-University Mainz|
Supervisory Board and comparable mandates
|2020 – today||Member of the Supervisory Board of Mutares Management SE|
|2020 – today||Chairman of the Advisory Board of MIP Pharma Holding GmbH|